Truvada (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Truvada drug offered from Avera McKennan Hospital. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | emtricitabine and tenofovir disoproxil fumarate |
SUBSTANCE NAME: | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-05-01 |
END MARKETING DATE: | 0000-00-00 |
Truvada HUMAN PRESCRIPTION DRUG Details:
Item Description | Truvada from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200; 300(mg/1; mg/1) |
START MARKETING DATE: | 2015-05-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0701_79dadcfd-c3a6-4ac9-8de7-e00d2b781a63 |
PRODUCT NDC: | 69189-0701 |
APPLICATION NUMBER: | NDA021752 |
Other EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE Pharmaceutical Manufacturers / Labelers: